Eric D. Eisenmann
Impact in
-
- Stress Responses and Cortisol
-
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Oncology 13
- Drug Transport and Resistance Mechanisms 8
-
- Protein Degradation and Inhibitors 3
- Cancer therapeutics and mechanisms 3
- Co-authors
- Sharyn D. Baker (21 shared papers)Alex Sparreboom (18 shared papers)Zahra Talebi (7 shared papers)Yan Jin (10 shared papers)Phillip R. Zoladz (5 shared papers)Boyd R. Rorabaugh (4 shared papers)Shuiying Hu (9 shared papers)Albert Bui (3 shared papers)
- Journals
- Pharmaceutics (5 papers)Clinical Cancer Research (2 papers)Blood (2 papers)The FASEB Journal (2 papers)Journal of Chromatography B (2 papers)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
Eric D. Eisenmann
29 papers receiving 296 citations
Peers
Comparison fields: 5 of 75
- Behavioral Neuroscience 30
- Hematology 54
- Biological Psychiatry 11
- Pharmacology 30
- Oncology 79
Countries citing papers authored by Eric D. Eisenmann
This map shows the geographic impact of Eric D. Eisenmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Eisenmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Eisenmann more than expected).
Fields of papers citing papers by Eric D. Eisenmann
This network shows the impact of papers produced by Eric D. Eisenmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Eisenmann. The network helps show where Eric D. Eisenmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric D. Eisenmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 36 | |
| 2 | 2020 | 33 | |
| 3 | 2020 | 23 | |
| 4 | 2015 | 22 | |
| 5 | 2021 | 18 | |
| 6 | 2020 | 16 | |
| 7 | 2019 | 15 | |
| 8 | 2021 | 13 | |
| 9 | 2022 | 13 | |
| 10 | 2016 | 13 | |
| 11 | 2020 | 11 | |
| 12 | 2022 | 10 | |
| 13 | 2016 | 10 | |
| 14 | 2022 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2018 | 8 | |
| 17 | 2022 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2018 | 6 | |
| 20 | 2023 | 4 |
About Eric D. Eisenmann
Eric D. Eisenmann is a scholar working on Oncology, Molecular Biology, Hematology, Genetics and Infectious Diseases, having authored 32 papers that have together received 298 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (5 papers), Protein Degradation and Inhibitors (3 papers), HIV/AIDS drug development and treatment (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Behavioral Neuroscience (30 citations), Hematology (54 citations), Biological Psychiatry (11 citations), Pharmacology (30 citations) and Oncology (79 citations). Eric D. Eisenmann has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Sharyn D. Baker, Alex Sparreboom, Zahra Talebi, Yan Jin, Phillip R. Zoladz, Boyd R. Rorabaugh, Shuiying Hu, Albert Bui, Kevin M. Huang and Sarah L. Seeley. Their work appears in journals such as Pharmaceutics, Clinical Cancer Research, Blood, The FASEB Journal and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.